Where do Candel Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Candel Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-64.6%+75.0pp	-139.6%-14.1pp	-125.5%-91.9pp	-33.6%—
Return on assets	-32.9%+41.6pp	-74.5%-10.7pp	-63.8%-41.3pp	-22.5%+36.7pp
Liquidity
Current ratio	13.5×+10.7×	2.8×+0.2×	2.6×-10.2×	12.8×-3.0×
Quick ratio	13.5×+10.7×	2.8×+0.2×	2.6×-10.2×	12.8×-3.0×
Cash ratio	13.3×+10.6×	2.7×+0.2×	2.5×-10.0×	12.5×-2.9×
Leverage
Debt-to-equity	0.1×-0.1×	0.2×-0.7×	0.9×+0.8×	0.1×0.0×
Debt-to-assets	0×-0.1×	0.1×-0.2×	0.3×+0.2×	0×0.0×
Interest coverage	-22.8×-6.8×	-16×-1.2×	-14.8×+5.5×	-20.3×—
Per Share
Book value per share	$0.98-53.2%	$2.09+375%	$0.44-73.4%	$1.66-51.3%
Valuation
Market capitalization	$693.87M+192%	$386.05M+806%	$42.6M-17.6%	$51.73M-76.9%
Enterprise value	$501.88M+220%	$295.13M+1,511%	$18.32M+216%	-$15.73M-111%
Price / book	5×+1.8×	5.8×+2.5×	3.3×+2.3×	1.1×-2.4×
Free cash flow yield	-7.1%+4.4pp	-7%+74.4pp	-81.5%-18.2pp	-63.2%-52.5pp
Earnings yield	-7.8%+8.8pp	-14.3%+74.8pp	-89.1%-52.7pp	-36.3%-19.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Candel Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Candel Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Candel Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.